Referencias
- Pérez
Alfonso R, Giansante E. Lupus eritematoso cutáneo. En: Rondón
Lugo A, editor. Dermatología Rondón Lugo vol II. 1era ed. Cap
107. Caracas; Reinaldo Godoy Editor; 1995. p. 993-1018.
- Giansante E.,
Pérez Alfonzo R., Muriel E., Camejo O. Oral Mucosal Lesions
in Systemic Lupus Erythematosus: A Clinical, Histopathological and Immunopathological
Study. Lupus 1998;7(1),21.
- Abbas AK.
Inmunología Celular y Molecular . Edit. Mc GRAW-HILL, 4 ed. 2002. p
3.
- http://www.uv.es/derma/Clindex/CLLECL/lupus.html
- Pérez
Alfonso R, Giansante E. Lupus eritematoso cutáneo Espectro
clínico, inmunológico y terapéutico. En: Rondón
Lugo A, editor. Temas dermatológicos: Pautas diagnósticas y
terapéuticas. 1era ed. Caracas; Tipografia Olympia; 2001. p. 185-204.
- Mora de Orta
S, Corado JA. Inmunología actual. 1era ed. Valencia, Venezuela;
Alfa impresores; 2003.
- www.odontologia-online.com/casos/part/lst/lst05/lst05.html
- www.uv.es/derma/clindex/CLLE/CL.lupus.html
- Correa JA.
Relación entre lupus eritematoso sistémico y discoide. En: http://www.monografias.com/trabajos12/semlupus/semlupus.shtml
9
- Seminario IX. Colagenosis,
manifestaciones cutáneas de enfermedades internas y dermatosis paraneoplásicas
En: www.UDL.es/usuaris/dermatol/DermatoAsignaturaWeb/CDROOM99/sem9/
temas/Dcha.html
- http://escuela.med.puc.cl/paginas/alumnos/quinto/temasquinto/medicina/45marquez.html
.
- Wallace, D. Dubois
EL. Lupus Erythematosus. Sixth Edition. Lippincott Williams and Wilkins
published, 2002:551-71.
- Calabrese L,
Fleischer AB. Thalidomide: current and potential clinical applications.
Am J Med 2000;108(6):487-95.
- Chen Met, Crowson
AN, Woofter M, Luca MB, Magro CM; Docetaxel induced subacute cutaneous
lupus erythematosus: report of 4 cases. Rheumatol 2004;31:818-20
- Ghaussy NO, Sibbitt
WL Jr, Qualls CR.. Cigarette smoking, alcohol consumption, and the
risk of systemic lupus erythematosus. A case control study. J. Rheumatol 2001;28(2):449-53.
- Berkow R, Fletcher
AJ, editores. El Manual Merck de diagnóstico y terapéutica.
9na ed. Barcelona, España: Grupo Editorial Oceano; 1994.
- Minami Y, Sasaki
T, Arai Y, Kurisu Y, Hisamichi S. Diet and systemic lupus erythematosus:
a 4 year prospective study of Japanese patients. J Rheumatol 2003;30(4):747-54.
- Wang C, Mayo
NE, Fortin PR. The relationship between health related quality of
life and disease activity and damage in systemic lupus erythematosus. J Rheumatol
2001;28(3):525-32.
- Cooper GS, Dooley
MA, Treadwell EL, St Clair EW, Gilkeson GS. Smoking and use of hair
treatment in relation to risk of developing systemic lupus erythematosus.
J Rheumatol 2001;28:2653-6
- Janowsky EC,
Kupper LL, Hulka BS. Meta-analyses of the relation between silicone
breast implants and the risk of connective-tissue diseases. N Engl J Med 2000;342(11):781-90.
- Osmola A, Namysl
J, Jagodzinski PP, Prokop J. Genetic background of cutaneous forms
of lupus erythematosus: update on current evidence. J Appl Genet 2004;45(1):77-86.
- Weidler C, Harle
P, Schedel J, Schmidt M, Scholmerich J, Straub RH. Patients with
rheumatoid arthritis and systemic lupus erythematosus have increased renal
excretion of mitogenic estrogens in relation to endogenous antiestrogens.
J Rheumatol 2004;31(3):489-94.
- Rider V.
Estrogens increases CD40 ligand expression in T cells from women mith systemic
lupus erythematosus. J Rheumatol 2001;28:2.646-9.
- Vera-Lastra O,
Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, et al. Correlation
of prolactin serum concentrations with clinical activity and remission in
patients with systemic lupus erythematosus. Effect of conventional treatment.
J Rheumatol 2003;30(10):2140-6.
- Werth V.
Current treatment of cutaneous lupus erythematosus. Dermatol Online J 2001;7(1):2.
- Walport MJ.
Complement. First of two parts .N Engl J Med 2001;344(14):1058-66.
